Plain-English translation of NCT06127927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an interventional left ventricular assist system—a small mechanical pump that helps your heart do its job when it's too weak to pump blood effectively on its own. The device is designed for patients with severe heart failure who haven't improved with medications alone. Researchers want to see if this pump can safely support patients and improve their chances of survival.
Many patients with severe heart disease don't get better with medications alone, and their hearts continue to fail. This treatment is being studied because it could bridge patients to recovery or give them time while waiting for a heart transplant, potentially saving lives that would otherwise be lost.
You would undergo a procedure to have the mechanical heart pump device placed in your body to support your heart's pumping. The trial has two phases: an initial phase with 6 patients to check safety, followed by a larger phase with 54 patients. You would need hospital stays and regular follow-up visits where doctors monitor how well the device is working, check for any complications, and assess whether your heart is recovering or stable enough for other treatments like transplantation.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China